Jessica Philpott

1.6k total citations
48 papers, 894 citations indexed

About

Jessica Philpott is a scholar working on Epidemiology, Genetics and Oncology. According to data from OpenAlex, Jessica Philpott has authored 48 papers receiving a total of 894 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Epidemiology, 22 papers in Genetics and 18 papers in Oncology. Recurrent topics in Jessica Philpott's work include Inflammatory Bowel Disease (20 papers), Microscopic Colitis (17 papers) and Colorectal Cancer Treatments and Studies (14 papers). Jessica Philpott is often cited by papers focused on Inflammatory Bowel Disease (20 papers), Microscopic Colitis (17 papers) and Colorectal Cancer Treatments and Studies (14 papers). Jessica Philpott collaborates with scholars based in United States, France and Canada. Jessica Philpott's co-authors include Martine Armand, Paul Hamosh, Margit Hamosh, Nitin Mehta, Jacob A. Kurowski, Theresa R. Henderson, Nancy K. Dwyer, Denis Lairon, Philip B. Miner and Pauline Funchain and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Jessica Philpott

41 papers receiving 873 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jessica Philpott United States 16 282 252 243 217 194 48 894
Anders Rönnblom Sweden 20 310 1.1× 486 1.9× 342 1.4× 500 2.3× 34 0.2× 41 1.4k
Johannes Spalinger Switzerland 16 36 0.1× 263 1.0× 246 1.0× 329 1.5× 73 0.4× 36 747
Clare Donnellan United Kingdom 7 110 0.4× 81 0.3× 124 0.5× 90 0.4× 66 0.3× 21 467
Amosy E. M’Koma United States 19 162 0.6× 356 1.4× 266 1.1× 521 2.4× 45 0.2× 43 1.0k
Thierry Dupré France 24 117 0.4× 149 0.6× 291 1.2× 148 0.7× 100 0.5× 60 1.4k
R N Allan United Kingdom 15 154 0.5× 312 1.2× 222 0.9× 290 1.3× 21 0.1× 23 713
Sebastian Zeki United Kingdom 13 130 0.5× 76 0.3× 313 1.3× 96 0.4× 67 0.3× 57 773
M. G. O'Riordain United Kingdom 11 131 0.5× 97 0.4× 190 0.8× 61 0.3× 123 0.6× 12 618
G. O. Young South Africa 13 77 0.3× 123 0.5× 283 1.2× 109 0.5× 88 0.5× 21 572
P Loizzi Italy 13 157 0.6× 155 0.6× 119 0.5× 79 0.4× 40 0.2× 50 641

Countries citing papers authored by Jessica Philpott

Since Specialization
Citations

This map shows the geographic impact of Jessica Philpott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jessica Philpott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jessica Philpott more than expected).

Fields of papers citing papers by Jessica Philpott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jessica Philpott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jessica Philpott. The network helps show where Jessica Philpott may publish in the future.

Co-authorship network of co-authors of Jessica Philpott

This figure shows the co-authorship network connecting the top 25 collaborators of Jessica Philpott. A scholar is included among the top collaborators of Jessica Philpott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jessica Philpott. Jessica Philpott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ratliff, Hunter N., Malek Shatila, Muhammad Ali Khan, et al.. (2023). The Safety of Immunosuppressants Used in the Treatment of Immune-Related Adverse Events due to Immune Checkpoint Inhibitors: a Systematic Review. Journal of Cancer. 14(16). 2956–2963. 10 indexed citations
2.
Faisal, Muhammad Salman, Daniela Allende, Joseph Sleiman, et al.. (2023). Characteristics of Immune Checkpoint Inhibitor-Associated Gastritis: Report from a Major Tertiary Care Center. The Oncologist. 28(8). 706–713. 11 indexed citations
3.
Garg, Rajat, Manik Aggarwal, Jean Paul Achkar, et al.. (2023). Real-world effectiveness and safety of ustekinumab and vedolizumab in elderly patients with Crohn’s disease. Indian Journal of Gastroenterology. 42(5). 718–723. 1 indexed citations
4.
Funchain, Pauline, et al.. (2022). S3482 Small Bowel Enteropathy Induced by Immune Checkpoint Inhibitors: A Case Series. The American Journal of Gastroenterology. 117(10S). e2191–e2191.
5.
Bachour, Salam, Ravi S. Shah, Ruishen Lyu, et al.. (2021). S699 Isolated Anastomotic Lesions Do Not Increase Risk for Severe Endoscopic Disease Progression in Postoperative Crohn’s Disease. The American Journal of Gastroenterology. 116(1). S316–S317. 1 indexed citations
6.
Bachour, Salam, Ravi S. Shah, Ruishen Lyu, et al.. (2021). Test Characteristics of Cross-sectional Imaging and Concordance With Endoscopy in Postoperative Crohn’s Disease. Clinical Gastroenterology and Hepatology. 20(10). 2327–2336.e4. 21 indexed citations
7.
Garg, Rajat, Manik Aggarwal, Robert S. Butler, et al.. (2021). Real-World Effectiveness and Safety of Ustekinumab in Elderly Crohn’s Disease Patients. Digestive Diseases and Sciences. 67(7). 3138–3147. 22 indexed citations
8.
Sleiman, Joseph, Wei Wei, Ravi S. Shah, et al.. (2021). Incidence of immune checkpoint inhibitor–mediated diarrhea and colitis (imDC) in patients with cancer and preexisting inflammatory bowel disease: a propensity score–matched retrospective study. Journal for ImmunoTherapy of Cancer. 9(6). e002567–e002567. 20 indexed citations
9.
Bachour, Salam, Ravi S. Shah, Florian Rieder, et al.. (2021). S712 Late Postoperative Crohn's Disease Recurrence Is Common and Differs by Baseline Inflammation. The American Journal of Gastroenterology. 116(1). S324–S325. 1 indexed citations
10.
Shah, Ravi, Joseph Sleiman, C. Roberto Simons-Linares, et al.. (2019). 93 Variations of Diagnosis and Management of Immune Checkpoint Inhibitor Pancreatic Injury (ICIPI) and Immune Checkpoint Inhibitor Pancreatitis: A Single Institution Experience. The American Journal of Gastroenterology. 114(1). S58–S58. 1 indexed citations
11.
Gao, Xianhua, et al.. (2018). Vedolizumab in the treatment of Crohn’s disease of the pouch. Gastroenterology report. 6(3). 184–188. 18 indexed citations
12.
Singh, Amandeep, et al.. (2018). Sa1829 - Vedolizumab for Chronic Antibiotic Refractory Pouchitis. Gastroenterology. 154(6). S–411. 1 indexed citations
13.
Philpott, Jessica. (2017). Etiology and pathogenesis of pouchitis. Seminars in Colon and Rectal Surgery. 28(3). 121–125.
14.
Horton, Nicholas J., Xianrui Wu, Jessica Philpott, et al.. (2016). Impact of Low Immunoglobulin G Levels on Disease Outcomes in Patients with Inflammatory Bowel Diseases. Digestive Diseases and Sciences. 61(11). 3270–3277. 10 indexed citations
15.
Bharadwaj, Shishira, Jessica Philpott, Matthew D. Barber, Lesley A. Graff, & Bo Shen. (2014). Womenʼs Health Issues After Ileal Pouch Surgery. Inflammatory Bowel Diseases. 20(12). 2470–2482. 11 indexed citations
16.
Anderson, Craig M., et al.. (2012). Hetero-multinuclear Ruthenium(III)/Platinum(II) Complexes That Potentially Exhibit Both Antimetastatic and Antineoplastic Properties. Inorganic Chemistry. 51(23). 12917–12924. 47 indexed citations
17.
Ali, Tauseef, et al.. (2012). Determination of serum antibodies to Clostridium difficile toxin B in patients with inflammatory bowel disease.. PubMed. 8(5). 313–7. 5 indexed citations
18.
Philpott, Jessica & Philip B. Miner. (2008). Antisense inhibition of ICAM-1 expression as therapy provides insight into basic inflammatory pathways through early experiences in IBD. Expert Opinion on Biological Therapy. 8(10). 1627–1632. 24 indexed citations
19.
Armand, Martine, Margit Hamosh, Jessica Philpott, et al.. (2003). Gastric Function in Children with Cystic Fibrosis: Effect of Diet on Gastric Lipase Levels and Fat Digestion. Pediatric Research. 55(3). 457–465. 21 indexed citations
20.
Armand, Martine, Margit Hamosh, Nitin Mehta, et al.. (1996). Effect of Human Milk or Formula on Gastric Function and Fat Digestion in the Premature Infant1. Pediatric Research. 40(3). 429–437. 201 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anders Rönnblom Breakdown of academic impact, for papers by Johannes Spalinger Breakdown of academic impact, for papers by Clare Donnellan Breakdown of academic impact, for papers by Amosy E. M’Koma Breakdown of academic impact, for papers by Thierry Dupré Breakdown of academic impact, for papers by R N Allan Breakdown of academic impact, for papers by Sebastian Zeki Breakdown of academic impact, for papers by M. G. O'Riordain Breakdown of academic impact, for papers by G. O. Young Breakdown of academic impact, for papers by P Loizzi
Rankless by CCL
2026